Literature DB >> 18245467

Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.

Ana Belén Martínez-Cruz1, Mirentxu Santos, M Fernanda Lara, Carmen Segrelles, Sergio Ruiz, Marta Moral, Corina Lorz, Ramón García-Escudero, Jesús M Paramio.   

Abstract

Squamous cell carcinomas (SCC) represent the most aggressive type of nonmelanoma skin cancer. Although little is known about the causal alterations of SCCs, in organ-transplanted patients the E7 and E6 oncogenes of human papillomavirus, targeting the p53- and pRb-dependent pathways, have been widely involved. Here, we report the functional consequences of the simultaneous elimination of Trp53 and retinoblastoma (Rb) genes in epidermis using Cre-loxP system. Loss of p53, but not pRb, produces spontaneous tumor development, indicating that p53 is the predominant tumor suppressor acting in mouse epidermis. Although the simultaneous inactivation of pRb and p53 does not aggravate the phenotype observed in Rb-deficient epidermis in terms of proliferation and/or differentiation, spontaneous SCC development is severely accelerated in doubly deficient mice. The tumors are aggressive and undifferentiated and display a hair follicle origin. Detailed analysis indicates that the acceleration is mediated by premature activation of the epidermal growth factor receptor/Akt pathway, resulting in increased proliferation in normal and dysplastic hair follicles and augmented tumor angiogenesis. The molecular characteristics of this model provide valuable tools to understand epidermal tumor formation and may ultimately contribute to the development of therapies for the treatment of aggressive squamous cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245467     DOI: 10.1158/0008-5472.CAN-07-3049

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

1.  Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma.

Authors:  Qi Ma; Lucas E Cavallin; Bin Yan; Shoukang Zhu; Elda Margarita Duran; Huili Wang; Laura P Hale; Chunming Dong; Ethel Cesarman; Enrique A Mesri; Pascal J Goldschmidt-Clermont
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-08       Impact factor: 11.205

2.  In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer.

Authors:  Mirentxu Santos; Mónica Martínez-Fernández; Marta Dueñas; Ramón García-Escudero; Begoña Alfaya; Felipe Villacampa; Cristina Saiz-Ladera; Clotilde Costa; Marta Oteo; José Duarte; Victor Martínez; Mª José Gómez-Rodriguez; Mª Luisa Martín; Manoli Fernández; Patrick Viatour; Miguel A Morcillo; Julien Sage; Daniel Castellano; Jose L Rodriguez-Peralto; Federico de la Rosa; Jesús M Paramio
Journal:  Cancer Res       Date:  2014-09-24       Impact factor: 12.701

3.  RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage.

Authors:  A Kathleen McClendon; Jeffry L Dean; Adam Ertel; Zhiyan Fu; Dayana B Rivadeneira; Christopher A Reed; Ryan J Bourgo; Agnieszka Witkiewicz; Sankar Addya; Christopher N Mayhew; H Leighton Grimes; Paolo Fortina; Erik S Knudsen
Journal:  Gastroenterology       Date:  2011-06-24       Impact factor: 22.682

Review 4.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

5.  Defining the origins of Ras/p53-mediated squamous cell carcinoma.

Authors:  Andrew C White; Kathy Tran; Joan Khuu; Christine Dang; Yongyan Cui; Scott W Binder; William E Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

6.  Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; M Fernanda Lara; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Kaoru Kiguchi; Agueda Buitrago; Clotilde Costa; Cristina Saiz; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; Marina Garín; Teresa Grande; Ana Bravo; John DiGiovanni; Jesús M Paramio
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

7.  Transgenic mice expressing constitutively active Akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma.

Authors:  Marta Moral; Carmen Segrelles; Ana Belén Martínez-Cruz; Corina Lorz; Mirentxu Santos; Ramón García-Escudero; Jerry Lu; Agueda Buitrago; Clotilde Costa; Cristina Saiz; José M Ariza; Marta Dueñas; Jose L Rodriguez-Peralto; Francisco J Martinez-Tello; Maria Rodriguez-Pinilla; Montserrat Sanchez-Cespedes; John Digiovanni; Jesús M Paramio
Journal:  In Vivo       Date:  2009 Sep-Oct       Impact factor: 2.155

Review 8.  20 years studying p53 functions in genetically engineered mice.

Authors:  Lawrence A Donehower; Guillermina Lozano
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

9.  A functional role of RB-dependent pathway in the control of quiescence in adult epidermal stem cells revealed by genomic profiling.

Authors:  Corina Lorz; Ramón García-Escudero; Carmen Segrelles; Marina I Garín; José M Ariza; Mirentxu Santos; Sergio Ruiz; María F Lara; Ana B Martínez-Cruz; Clotilde Costa; Agueda Buitrago-Pérez; Cristina Saiz-Ladera; Marta Dueñas; Jesús M Paramio
Journal:  Stem Cell Rev Rep       Date:  2010-06       Impact factor: 5.739

10.  The Rb tumor suppressor regulates epithelial cell migration and polarity.

Authors:  Tiziana Parisi; Michele Balsamo; Frank Gertler; Jacqueline A Lees
Journal:  Mol Carcinog       Date:  2018-08-26       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.